These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9622094)

  • 21. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
    Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
    Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nipple discharge and the value of MR imaging.
    Tjalma WA; Verslegers IO
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):234-6. PubMed ID: 15262363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 8. The dilemma of in situ carcinoma of the breast.
    Fentiman IS
    Int J Clin Pract; 2001 Dec; 55(10):680-3. PubMed ID: 11777293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [1st revision of the National Consensus on Breast Cancer Treatment].
    Consenso Nacional sobre Tratamiento del Cáncer Mamario
    Ginecol Obstet Mex; 2002 Jul; 70():349-60. PubMed ID: 12221911
    [No Abstract]   [Full Text] [Related]  

  • 25. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
    Valdes EK; Boolbol SK; Ali I; Feldman SM; Cohen JM
    Ann Surg Oncol; 2007 Oct; 14(10):2940-5. PubMed ID: 17632761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting difficult accessible breast lesions: MRI-guided needle localization using a freehand technique in a 3.0 T closed bore magnet.
    Meeuwis C; Peters NH; Mali WP; Gallardo AM; van Hillegersberg R; Schipper ME; van den Bosch MA
    Eur J Radiol; 2007 May; 62(2):283-8. PubMed ID: 17218074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER; Park A; Borgen PI; Morris E; Montgomery LL
    Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
    Schelfout K; Van Goethem M; Kersschot E; Colpaert C; Schelfhout AM; Leyman P; Verslegers I; Biltjes I; Van Den Haute J; Gillardin JP; Tjalma W; Van Der Auwera JC; Buytaert P; De Schepper A
    Eur J Surg Oncol; 2004 Jun; 30(5):501-7. PubMed ID: 15135477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of breast cancer: MDCT versus MRI.
    Tozaki M
    Breast Cancer; 2008; 15(3):205-11. PubMed ID: 18443898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
    Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast.
    Kepple J; Layeeque R; Klimberg VS; Harms S; Siegel E; Korourian S; Gusmano F; Henry-Tillman RS
    Am J Surg; 2005 Oct; 190(4):623-7. PubMed ID: 16164936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential role of dynamic MRI in assessing the effectiveness of high-intensity focused ultrasound ablation of breast cancer.
    Kim SH; Jung SE; Kim HL; Hahn ST; Park GS; Park WC
    Int J Hyperthermia; 2010; 26(6):594-603. PubMed ID: 20707653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update of the NCCN guidelines for treatment of breast cancer.
    Oncology (Williston Park); 1997 Nov; 11(11A):199-220. PubMed ID: 9430190
    [No Abstract]   [Full Text] [Related]  

  • 35. Duodenal involvement by breast cancer.
    Campanile F; Maurea S; Mainenti P; Corvino A; Imbriaco M
    Breast J; 2012; 18(6):615-6. PubMed ID: 23110410
    [No Abstract]   [Full Text] [Related]  

  • 36. Management and Outcomes in Metaplastic Breast Cancer.
    Tzanninis IG; Kotteas EA; Ntanasis-Stathopoulos I; Kontogianni P; Fotopoulos G
    Clin Breast Cancer; 2016 Dec; 16(6):437-443. PubMed ID: 27431460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A desmoid tumour associated with a breast prosthesis.
    Gergelé F; Guy F; Collin F; Krausé D
    Diagn Interv Imaging; 2012 Mar; 93(3):e200-3. PubMed ID: 22421285
    [No Abstract]   [Full Text] [Related]  

  • 38. Breast cancer in a patient with agnogenic myeloid metaplasia.
    Arik Z; Ozkan C; Ozdemir E; Altundag K
    South Med J; 2010 Oct; 103(10):1075-6. PubMed ID: 20818318
    [No Abstract]   [Full Text] [Related]  

  • 39. Mastopexy sutures masquerading as an organic breast lesion on MRI scan.
    Tomouk T; Mahler-Araujo B; Gaskarth MT; Malata CM; Forouhi P
    J Plast Reconstr Aesthet Surg; 2014 Jul; 67(7):e182-3. PubMed ID: 24559730
    [No Abstract]   [Full Text] [Related]  

  • 40. Invasive Lobular Carcinoma of the Breast: Toward Tailoring Therapy?
    Djerroudi L; Cabel L; Bidard FC; Vincent-Salomon A
    J Natl Cancer Inst; 2022 Nov; 114(11):1434-1436. PubMed ID: 36239762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.